Nozin Nasal Sanitizer® antiseptic is a patented, non-antibiotic topical product aimed at reducing the nasal carriage of bacteria. Clinically proven to reduce the presence of harmful bacteria, such as Staph aureus, and applied to the vestibule of the nose via the convenient single-use POPswab ampule, Nozin® Nasal Sanitizer® antiseptic combines natural emollients and ethanol to kill 99.99 percent of germs.

2.  Nozin Nasal Sanitizer® antiseptic is a patented, non-
antibiotic topical product aimed at reducing the
nasal carriage of bacteria. Clinically proven to
reduce the presence of harmful bacteria, such as
Staph aureus, and applied to the vestibule of the
nose via the convenient single-use POPswab ampule,
Nozin® Nasal Sanitizer® antiseptic combines natural
emollients and ethanol to kill 99.99 percent of germs.
The Nozin product is being used by healthcare
facilities for infection control, to help reduce
pathogens, improve patient care and lower costs.

3.  In a recent press article found at cnbc.com
(http://www.cnbc.com/id/102530012), health
professionals at Marshall Medical Center, a nonprofit,
independent health provider in El Dorado County,
California, discuss the successful use of Nozin® Nasal
Sanitizer® antiseptic to reduce the risk of infection while
improving quality of care, increasing patient satisfaction
and eliminating a major category of costly contact
precautions. From the article: “Our nurses like the program
because, without having to gown and glove each time
that they enter a room, they can provide more responsive
care, ” says Brian Kendler, RN, Infection Preventionist on
the Marshall infection control team. “Our patients seem to
really like the Nozin product as evidenced by both use
compliance and the increased satisfaction verbalized
since implementation. It’s been a true win-win.”

4.  A major concern in infection control is the
buildup of antibiotic resistance in pathogens
due to the overuse of antibiotic drugs. Kendler
states, “As an antiseptic and not an antibiotic,
the Nozin product conforms to the goal of our
antibiotic stewardship directives. The Nozin
nonantibiotic approach to reducing nasal
colonization makes a lot of sense to me.” For
more about Nozin visit nozin.com and
nozinpro.com. The article can also be found at
http://finance.yahoo.com/news/nozin-nasal-
drug-reduces-risk-120900069.html